2008 U.S. Inflammatory Disease Drug Delivery - Patient Perspective

 

Regular Price: USD 10,000

Special Price USD 7,000

30% OFF

* Required Fields

Regular Price: USD 10,000

Special Price USD 7,000

PAY BY INVOICE

Be the first to review this product

This study encompasses feedback provided by U.S. patients treated for inflammatory diseases on aspects of drug delivery and drug treatment, enabling interested stakeholders to gain insight on current and future trends. Analysis includes issues such as awareness, usage, preferences, influencing criteria, patient compliance, desired delivery types to be made available, as well as feedback on the role the device plays in the prescribing decision for a drug.

Table of Contents

2008 U.S. Inflammatory Disease Drug Delivery - Patient Perspective, U.S. Drug Delivery: Inflammatory DiseasePatient Perspective2008 U.S. Inflammatory Diseases Drug Delivery: Patient Perspective




Related Research

Release Date : 26-Sep-17

Region : North America

Release Date : 25-Sep-17

Region : North America

Release Date : 19-Sep-17

Region : North America

Release Date : 08-Sep-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.